We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$2.13B
(+17%)
Cap. Flow
+$1.52B
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$132M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$100M |
| 4 |
Fidelity National Information Services
FIS
|
+$94.3M |
| 5 |
FedEx
FDX
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$97.2M |
| 2 |
Booking.com
BKNG
|
+$94.2M |
| 3 |
Phillips 66
PSX
|
+$82.9M |
| 4 |
Gilead Sciences
GILD
|
+$73.9M |
| 5 |
Snowflake
SNOW
|
+$51.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.09% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
nLIGHT
LASR
$3.57B
| $255K | ﹤0.01% |
25,108
-36,402
| -59% | -$376K |
|
|
OSG
877
DELISTED
Overseas Shipholding Group Inc.
OSG
| $253K | ﹤0.01% |
87,481
| – | – |
|
878
Compass
COMP
$8.88B
| $252K | ﹤0.01% |
108,071
-2,739,343
| -96% | -$7.19M |
|
879
Bridgewater Bancshares
BWB
$585M
| $248K | ﹤0.01% |
14,007
+235
| +2% | +$4.31K |
|
880
Emcor
EME
$31.4B
| $248K | ﹤0.01% |
1,672
-1,824
| -52% | -$259K |
|
881
e.l.f. Beauty
ELF
$4.96B
| $247K | ﹤0.01% |
+4,464
| New | +$219K |
|
882
Teladoc Health
TDOC
$1.69B
| $247K | ﹤0.01% |
+10,437
| New | +$281K |
|
883
AngioDynamics
ANGO
$593M
| $245K | ﹤0.01% |
+17,809
| New | +$248K |
|
|
RAD
884
DELISTED
Rite Aid Corporation
RAD
| $245K | ﹤0.01% |
73,222
-9,547
| -12% | -$45.4K |
|
885
MetLife
MET
$62.7B
| $241K | ﹤0.01% |
3,331
-125,881
| -97% | -$9.02M |
|
886
eHealth
EHTH
$43.2M
| $239K | ﹤0.01% |
49,448
-51,394
| -51% | -$192K |
|
|
LBAI
887
DELISTED
Lakeland Bancorp Inc
LBAI
| $238K | ﹤0.01% |
13,498
-5,702
| -30% | -$102K |
|
888
Hewlett Packard
HPE
$60.4B
| $237K | ﹤0.01% |
14,842
+3,265
| +28% | +$48.1K |
|
889
Lineage Cell Therapeutics
LCTX
$267M
| $237K | ﹤0.01% |
202,202
-55,259
| -21% | -$69.6K |
|
890
InfuSystem Holdings
INFU
$200M
| $231K | ﹤0.01% |
26,619
-800
| -3% | -$6.52K |
|
891
Gates Industrial Corporation Ltd.
GTES
$6.69B
| $231K | ﹤0.01% |
20,228
-41,596
| -67% | -$459K |
|
892
Avanos Medical
AVNS
| $229K | ﹤0.01% |
+8,473
| New | +$207K |
|
|
WCC
893
WESCO International
WCC
$16.1B
| $225K | ﹤0.01% |
1,794
| – | – |
|
894
Metropolitan Bank Holding Corp
MCB
$1.14B
| $223K | ﹤0.01% |
3,797
+60
| +2% | +$3.8K |
|
895
First Western Financial
MYFW
$308M
| $217K | ﹤0.01% |
7,695
-8,366
| -52% | -$233K |
|
896
Torrid Holdings
CURV
$271M
| $217K | ﹤0.01% |
+73,167
| New | +$299K |
|
|
NXRT
897
NexPoint Residential Trust
NXRT
$686M
| $216K | ﹤0.01% |
4,960
-41,059
| -89% | -$1.84M |
|
898
Bristol-Myers Squibb
BMY
$130B
| $216K | ﹤0.01% |
+2,998
| New | +$226K |
|
899
Alta Equipment Group
ALTG
$207M
| $215K | ﹤0.01% |
16,320
+761
| +5% | +$9.16K |
|
|
AMWD
900
DELISTED
American Woodmark
AMWD
| $215K | ﹤0.01% |
+4,394
| New | +$218K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2022 Portfolio in Review
As of Q4 2022, Jacobs Levy Equity Management held 1,089 positions worth $14.8B, up 17% from $12.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.52B of net new capital in Q4 2022, opening 119 new positions and adding to 321 existing holdings. Its largest new stake was Fidelity National Information Services: 1,326,663 shares worth $90M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Booking.com, an estimated $94.2M trimmed.
- Jacobs Levy Equity Management's largest Q4 2022 buy was Fidelity National Information Services: 1,326,663 shares worth $90M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q4 2022, an estimated $132M increase.
- Jacobs Levy Equity Management's biggest Q4 2022 reduction was Booking.com, cutting an estimated $94.2M.
- Jacobs Levy Equity Management fully exited Cigna in Q4 2022, selling an estimated $97.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q4 2022.
- Jacobs Levy Equity Management opened 119 new positions and closed 155 in Q4 2022.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.